Dr. Eric B. Geller, MD

Dr. Geller practices at Hudson Terrace Medical in Englewood Cliffs, New Jersey.

Dr. Geller's NPI, 1780788992, was assigned on September 8, 2006. Dr. Geller graduated from The Warren Alpert Medical School of Brown University in 1989. Dr. Geller holds New Jersey license MA68010.

Dr. Geller's primary practice is Hudson Terrace Medical, at 464 Hudson Terrace, Englewood Cliffs, NJ 07632. The practice phone is (201) 503-0066.

Dr. Geller's primary practice is Hudson Terrace Medical in Englewood Cliffs, New Jersey. Dr. Geller is also affiliated with Morristown Medical Center. The medical group on file is Hudson MD Group. Dmand AI also links Dr. Geller to 4 more hospitals, 3 group practices and clinics, 3 medical groups and 1 ambulatory surgery center, each named with a free account. Dr. Geller's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Geller practices, 10 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Geller's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Geller is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Geller's licenses on file in 3 states: New Jersey, Ohio and Massachusetts.

Dmand AI lists acute mini-stroke (TIA), epilepsy, migraine and chronic headache and seizures among the conditions Dr. Geller treats.

CMS data shows 2,196 Medicare services from Dr. Geller across 25 procedure codes in 2024, for 685 Medicare patients. Medicare paid $268,523 for them.

CMS counts 685 Medicare patients who saw Dr. Geller in 2024. The largest group is under 65, with 267 patients. 72% of them have high cholesterol, and 62% have high blood pressure. 43% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Geller's median patient age at 52, with 49% women.

In 2024, Dr. Geller wrote 8,437 Medicare Part D claims for 491 patients. 80% of them were for generic drugs. CMS names the drug for 8,248 of them, across 81 drugs with 11 or more claims each, at $2,901,817 in total drug cost. In 2023, CMS named 8,080 claims across 76 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Geller for performance year 2024, reported through an alternative payment model (APM). Dr. Geller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Geller as offering telehealth.

Dmand AI links 29 papers to Dr. Geller, published from 2010 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Epilepsy, Vagus Nerve Stimulation and Drug Resistant Epilepsy. Dr. Geller has published most often in Epilepsy Behav. Dr. Geller's most frequent co-authors are Orrin Devinsky, MD, Chad Edward Carlson, MD and Werner K. Doyle, MD.

Dmand AI links Dr. Geller to 2 clinical trials. Conditions studied include Periventricular Nodular Heterotopia, Seizures and Epilepsy.

CMS Open Payments shows 211 general payments to Dr. Geller from 35 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Neuropace, Inc. paid the most, $46,933.

Dmand AI lists 7 awards for Dr. Geller, most recently Fellow of the American Epilepsy Society in 2018.

Dr. Geller graduated from The Warren Alpert Medical School of Brown University in 1989. Dr. Geller is a member of AAN, AES and MMS.

Dr. Geller is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.